TinaHashiRN said:The trade-off is reversibility against privacy and there is no option that gives you both.
Agreed, and one detail people underrate: an irreversible payment removes your only leverage in a dispute, so it should be the last step rather than the first.
DanielChem_CHI said:Worth adding the genuine exception, because it is real and narrow: a change made for an identified patient where the prescriber determines it produces…
This answered a question I did not know how to ask. I will report back once I have actually tried it.
TinaHashiRN said:The trade-off is reversibility against privacy and there is no option that gives you both.
FDA inspection results for compounding pharmacies selling compounded supply: you can look up any 503B facility's FDA inspection history on the FDA website.
Check for: Form 483 observations (violations), warning letters, and recall history. A clean inspection record is a strong indicator of quality. My pharmacy has had 1 Form 483 observations in their last 2 inspections.
This is public information. Use it. Link: fda.gov/inspections-compliance-enforcement-and-criminal-investigations
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultswanda_boise said:My pharmacy stopped supplying with three weeks notice and a letter that explained nothing, so I went and read the statute.
Compounding pharmacy customer here with experience relevant to compounded supply.
I've ordered from 3 different compounding pharmacies over the past year. The quality variation is real — purity ranged from 94% to 101% of label claim based on independent Janoshik testing.
My current compounder (a 503B facility) has been consistently 98-101% purity across 6 orders. I pay $114/month vs $1,304 for brand. The savings are substantial and the product is equivalent in my experience.
Re: compounded supply — this applies whether you're using brand or compounded. The clinical principles are the same.